SEC’s 20-Day Countdown: Approve the 21 Shares XRP ETF or Watch It Go Live

The clock is ticking—regulators have less than three weeks to greenlight the first XRP-backed ETF or let it hit the market by default.

The ETF Deadline Shakeup

No extensions, no compromises. If the SEC doesn’t act by November 28, 21 Shares’ filing automatically goes live—whether Wall Street’s old guard likes it or not.

Crypto’s Regulatory End-Run

Another passive-aggressive showdown between innovators and paper-pushers. Meanwhile, traditional finance still thinks 'blockchain' is a type of ski binding.

The moment the 21Shares Ripple XRP news broke, its price surged a massive 6%, trading around $2.31, with volume jumping nearly 15%. If the regulator stays silent, the listed funds could automatically go live, unleashing what traders are calling a potential “God Candle 2.0.”

Countdown To November 27: Why SEC XRP ETF Deadline Matters

Under Section 8(a) of the Securities Act of 1933, the regulator has exactly 20 days to respond to 21 Shares XRP ETF filing. If they don't act, then it will automatically be cleared for launch, no further approvals needed!

That makes November 27 the most anticipated deadline for XRP ETF sec approval. Analyst Nate Geraci calls this the “final lap” toward institutional validation. 

We're seeing giants like Franklin Templeton and Canary Capital already positioning themselves; the Franklin Templeton $XRPZ exchange traded funds is even listed on DTCC, the very last step before trading can go live.

By November 27, the market could witness Ripple’s first-ever U.S.listed spot listed fund. A mega event capable of flipping sentiment across the entire altcoin world.

Institutional Signal: What This 21Shares News Means For Industry?

These filings aren’t just bureaucracy, they’re Wall Street smoke signals. Every new submission from a major issuer screams “institutional money incoming.”

The last time this altcoins got such a powerful catalyst was its 2023 court victory against the security exchange commission, which triggered a huge 70% surge in days. 

Now, with global liquidity chasing crypto listed funds after the BTC and ETH spot approvals, the 21Shares XRP ETF filing approval could be the key to massive capital inflows.

Price Surge Technical Analysis: Bulls Loading Up

The TradingView price chart suggests a classic consolidation, or a "healthy pause," before the next big move. At the time of writing ripple is trading at $2.31, reflecting a massive surge of around 6% after a few days of downfall.

• RSI value of 55.59 shows the asset has cooled slightly but stays above 50, which is neutral-bullish. If it reclaims 60, the token could rocket toward $2.45–$2.50.

• MACD shows a bullish crossover has formed, reflecting its calm before the next wave of expansion.

Key Levels to Watch: Bulls are defending the immediate support zone of $2.25 – $2.28, and resistance at $2.40 – $2.45 is the breakout trigger. The overall chart shows a V-reversal from $2.10, making higher lows. 

21 Shares XRP ETF Price Prediction: What Can Happen?

If SEC approves 21 Shares ETF filing, then top analysts at Coingabbar believe that it could repeat its 2023 price surge pattern.

• Short Term: With speculation running high, the outlook is bullish, targeting $2.25 – $2.55.

• Mid Term: An actual greenlight from the regulators and liquidity inflow could push the price to a bullish range of $2.60 to $3.10. But on the flip side if the decision gets delayed then the token might find its support zone near $2.05 or $2.10.

• Long Term: Driven by institutional adoption and payments utility, a strongly bullish forecast sees $4.50 – $6.00.

Conclusion: The 20-Day Test of Faith

The 21Shares XRP ETF Filing news has ignited a massive price run, but only time will tell whether the momentum will hold or face correction. With technical indicators signaling bullish run,  and institutional whales circling, the setup is ready for liftoff. Whether the SEC acts or not, traders are closely watching every price movement, and the most important November 27 deadline.

Disclaimer: This article is for informational purposes only, and does not support investment advice. Always DYOR before making any financial decision.